Exposure to fibroblast-CM paradoxically hyperactivates the PI3K signaling cascade in PIK3CA-mut/KRAS-mut/PTEN-competent CRC cells, resulting in increased sensitivity to the growth inhibitory effects of pharmacologic double PI3K/mTOR blockade. The gene discussed is KRAS; the disease is colorectal carcinoma.